ClinVar Miner

Submissions for variant GRCh38/hg38 2q31.2(chr2:178553579-178637393)x1

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV003327626 SCV004034277 pathogenic Dilated cardiomyopathy 1G 2023-08-24 criteria provided, single submitter research A confirmed de novo heterozygous deletion of exons 225-334 in TTN (NM_001267550.2) was identified by exome sequencing and confirmed by targeted chromosomal microarray of the TTN gene in one individual with dilated cardiomyopathy ([GRCh38] chr2:178553579_178637393x1)(PMID: 34740920). The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. This intragenic variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at exon 3 and leads to a premature termination codon. This alteration is then predicted to lead to a truncated or absent. The TTN gene is known to be haploinsufficient, and has been assessed by the ClinGen Dosage Sensitivity Working Group (https://search.clinicalgenome.org/kb/gene-dosage). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant dilated cardiomyopathy. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.90 points, 3: 0 points, 4-5: 0.15 points; Total: 1.05 points; Riggs 2020 (PMID: 31690835).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.